首页> 外国专利> VASCULAR ENDOTHELIAL CELL GROWTH FACTOR THAT IS UNACCOMPANIED BY ASSOCIATED NATIVE GLYCOSYLATION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND USE THEREOF IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING TRAUMA AFFECTING THE VASCULAR ENDOTHELIUM

VASCULAR ENDOTHELIAL CELL GROWTH FACTOR THAT IS UNACCOMPANIED BY ASSOCIATED NATIVE GLYCOSYLATION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND USE THEREOF IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING TRAUMA AFFECTING THE VASCULAR ENDOTHELIUM

机译:伴随的天然糖基化,包含它的药物成分及其在制造治疗创伤性血管内皮损伤的药物中使用时所不伴随的血管内皮细胞生长因子

摘要

DNA isolates coding for a vascular endothelial cell growth factor may be used to produce the protein via recombinant expression systems. Such protein is useful therapeutically to treat conditions in which a selective action on the vascular endothelial cells, in the absence of excessive connective tissue proliferation, is desirable.
机译:编码血管内皮细胞生长因子的DNA分离物可用于通过重组表达系统生产蛋白质。此类蛋白质可用于治疗需要在不过度结缔组织增殖的情况下对血管内皮细胞产生选择性作用的疾病。

著录项

  • 公开/公告号IL154797D0

    专利类型

  • 公开/公告日2003-10-31

    原文格式PDF

  • 申请/专利权人 GENENTECH INC.;

    申请/专利号IL20030154797

  • 发明设计人

    申请日2003-03-06

  • 分类号7C07KA;

  • 国家 IL

  • 入库时间 2022-08-22 00:02:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号